Claudio Dansky Ullmann

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint A population-based study of therapy and survival for patients with head and neck cancer treated in the community
    Claudio Dansky Ullmann
    Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA
    Cancer 118:4452-61. 2012
  2. pmc NF-κB as potential target in the treatment of melanoma
    Gabriele Madonna
    Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy
    J Transl Med 10:53. 2012
  3. pmc Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
    Paolo A Ascierto
    Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy
    J Transl Med 9:32. 2011
  4. pmc Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival
    Helen M Parsons
    From the Applied Research Program, National Cancer Institute, Bethesda, MD Information Management Services, Inc, Calverton, MD and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
    Cancer J 20:97-104. 2014

Collaborators

  • Linda C Harlan
  • Helen M Parsons
  • Vickie L Shavers
  • Claudio Dansky Ullmann
  • Gabriele Madonna
  • Giuseppe Palmieri
  • Paolo A Ascierto
  • Claudio Dansky Ullman
  • Paolo Antonio Ascierto
  • Jennifer L Stevens
  • Giusy Gentilcore
  • Mohamed Kashani-Sabet
  • Peter P Lee
  • John M Kirkwood
  • ALISTAIR COCHRAN
  • Stefano Bertuzzi
  • Soldano Ferrone
  • Antoni Ribas
  • Mary Hendrix
  • Bernard A Fox
  • Ena Wang
  • Jerome Galon
  • Licia Rivoltini
  • Michele Maio
  • Douglas J Schwartzentruber
  • Keith Flaherty
  • Eleonora De Maio
  • Nicola Mozzillo
  • Frederic F Lehmann
  • David F Stroncek
  • Ruth Halaban
  • James Yang
  • Mario Sznol
  • Franco M Marincola

Detail Information

Publications4

  1. doi request reprint A population-based study of therapy and survival for patients with head and neck cancer treated in the community
    Claudio Dansky Ullmann
    Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA
    Cancer 118:4452-61. 2012
    ..The objective of this study was to examine patterns of care and survival in a population-based sample of patients with head and neck cancer (HNC) who were treated in the community or in hospitals that had residency training programs...
  2. pmc NF-κB as potential target in the treatment of melanoma
    Gabriele Madonna
    Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy
    J Transl Med 10:53. 2012
    ..Among these, NFκB is another pathway that melanoma tumors use to achieve survival, proliferation and resistance to apoptosis. Inhibition of NF-κB activation appears to be a very promising option for anti-cancer therapies...
  3. pmc Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
    Paolo A Ascierto
    Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy
    J Transl Med 9:32. 2011
    ..Four topics of discussion were identified: New pathways in Melanoma, Biomarkers, Clinical Trials and New Molecules and Strategies...
  4. pmc Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival
    Helen M Parsons
    From the Applied Research Program, National Cancer Institute, Bethesda, MD Information Management Services, Inc, Calverton, MD and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
    Cancer J 20:97-104. 2014
    ..Whereas treatment patterns and outcomes have been evaluated for patients with SCLC in clinical trials, population-based practice patterns are not well known...